140 related articles for article (PubMed ID: 30684561)
1. Prophylactic efficacy of a human monoclonal antibody against MERS-CoV in the common marmoset.
de Wit E; Feldmann F; Horne E; Okumura A; Cameroni E; Haddock E; Saturday G; Scott D; Gopal R; Zambon M; Corti D; Feldmann H
Antiviral Res; 2019 Mar; 163():70-74. PubMed ID: 30684561
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic and therapeutic efficacy of mAb treatment against MERS-CoV in common marmosets.
de Wit E; Feldmann F; Okumura A; Horne E; Haddock E; Saturday G; Scott D; Erlandson KJ; Stahl N; Lipsich L; Kyratsous CA; Feldmann H
Antiviral Res; 2018 Aug; 156():64-71. PubMed ID: 29885377
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.
Corti D; Zhao J; Pedotti M; Simonelli L; Agnihothram S; Fett C; Fernandez-Rodriguez B; Foglierini M; Agatic G; Vanzetta F; Gopal R; Langrish CJ; Barrett NA; Sallusto F; Baric RS; Varani L; Zambon M; Perlman S; Lanzavecchia A
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10473-8. PubMed ID: 26216974
[TBL] [Abstract][Full Text] [Related]
4. Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset.
Chen Z; Bao L; Chen C; Zou T; Xue Y; Li F; Lv Q; Gu S; Gao X; Cui S; Wang J; Qin C; Jin Q
J Infect Dis; 2017 Jun; 215(12):1807-1815. PubMed ID: 28472421
[TBL] [Abstract][Full Text] [Related]
5. Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection.
Houser KV; Gretebeck L; Ying T; Wang Y; Vogel L; Lamirande EW; Bock KW; Moore IN; Dimitrov DS; Subbarao K
J Infect Dis; 2016 May; 213(10):1557-61. PubMed ID: 26941283
[TBL] [Abstract][Full Text] [Related]
6. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection.
Qiu H; Sun S; Xiao H; Feng J; Guo Y; Tai W; Wang Y; Du L; Zhao G; Zhou Y
Antiviral Res; 2016 Aug; 132():141-8. PubMed ID: 27312105
[TBL] [Abstract][Full Text] [Related]
7. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
8. Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease.
Tao X; Garron T; Agrawal AS; Algaissi A; Peng BH; Wakamiya M; Chan TS; Lu L; Du L; Jiang S; Couch RB; Tseng CT
J Virol; 2016 Jan; 90(1):57-67. PubMed ID: 26446606
[TBL] [Abstract][Full Text] [Related]
9. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.
Ying T; Li H; Lu L; Dimitrov DS; Jiang S
Microbes Infect; 2015 Feb; 17(2):142-8. PubMed ID: 25456101
[TBL] [Abstract][Full Text] [Related]
10. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.
Li Y; Wan Y; Liu P; Zhao J; Lu G; Qi J; Wang Q; Lu X; Wu Y; Liu W; Zhang B; Yuen KY; Perlman S; Gao GF; Yan J
Cell Res; 2015 Nov; 25(11):1237-49. PubMed ID: 26391698
[TBL] [Abstract][Full Text] [Related]
11. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
[TBL] [Abstract][Full Text] [Related]
12. A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein.
Chen Y; Lu S; Jia H; Deng Y; Zhou J; Huang B; Yu Y; Lan J; Wang W; Lou Y; Qin K; Tan W
Emerg Microbes Infect; 2017 May; 6(5):e37. PubMed ID: 28536429
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
14. A Human DPP4-Knockin Mouse's Susceptibility to Infection by Authentic and Pseudotyped MERS-CoV.
Fan C; Wu X; Liu Q; Li Q; Liu S; Lu J; Yang Y; Cao Y; Huang W; Liang C; Ying T; Jiang S; Wang Y
Viruses; 2018 Aug; 10(9):. PubMed ID: 30142928
[TBL] [Abstract][Full Text] [Related]
15. Enhanced inflammation in New Zealand white rabbits when MERS-CoV reinfection occurs in the absence of neutralizing antibody.
Houser KV; Broadbent AJ; Gretebeck L; Vogel L; Lamirande EW; Sutton T; Bock KW; Minai M; Orandle M; Moore IN; Subbarao K
PLoS Pathog; 2017 Aug; 13(8):e1006565. PubMed ID: 28817732
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection.
Han HJ; Liu JW; Yu H; Yu XJ
Viruses; 2018 Nov; 10(12):. PubMed ID: 30513619
[TBL] [Abstract][Full Text] [Related]
17. A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice.
Niu P; Zhao G; Deng Y; Sun S; Wang W; Zhou Y; Tan W
Sci China Life Sci; 2018 Oct; 61(10):1280-1282. PubMed ID: 30091015
[No Abstract] [Full Text] [Related]
18. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of candidate vaccine approaches for MERS-CoV.
Wang L; Shi W; Joyce MG; Modjarrad K; Zhang Y; Leung K; Lees CR; Zhou T; Yassine HM; Kanekiyo M; Yang ZY; Chen X; Becker MM; Freeman M; Vogel L; Johnson JC; Olinger G; Todd JP; Bagci U; Solomon J; Mollura DJ; Hensley L; Jahrling P; Denison MR; Rao SS; Subbarao K; Kwong PD; Mascola JR; Kong WP; Graham BS
Nat Commun; 2015 Jul; 6():7712. PubMed ID: 26218507
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets.
van Doremalen N; Falzarano D; Ying T; de Wit E; Bushmaker T; Feldmann F; Okumura A; Wang Y; Scott DP; Hanley PW; Feldmann H; Dimitrov DS; Munster VJ
Antiviral Res; 2017 Jul; 143():30-37. PubMed ID: 28389142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
